Search by Drug Name or NDC
NDC 61476-0104-05 Alyglo 100 mg/mL Details
Alyglo 100 mg/mL
Alyglo is a INTRAVENOUS LIQUID in the PLASMA DERIVATIVE category. It is labeled and distributed by GC Biopharma Corp.. The primary component is HUMAN IMMUNOGLOBULIN G.
Product Information
| NDC | 61476-0104 |
|---|---|
| Product ID | 61476-104_692b3911-b195-4499-9790-37e0812b3cde |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Alyglo |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Human immunoglobulin G |
| Product Type | PLASMA DERIVATIVE |
| Dosage Form | LIQUID |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/mL |
| Substance Name | HUMAN IMMUNOGLOBULIN G |
| Labeler Name | GC Biopharma Corp. |
| Pharmaceutical Class | Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125743 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61476-0104-05 (61476010405)
| NDC Package Code | 61476-104-05 |
|---|---|
| Billing NDC | 61476010405 |
| Package | 1 VIAL, GLASS in 1 CARTON (61476-104-05) / 50 mL in 1 VIAL, GLASS (61476-104-01) |
| Marketing Start Date | 2023-12-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |